Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021

Date: January 31, 2017
Pages: 138
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L3599B1873AEN
Leaflet:

Download PDF Leaflet

Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021
The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The global lung cancer surgery market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. The monitoring and visualizing systems segment is expected to register the highest CAGR during the forecast period. Increasing awareness about advanced treatment procedures such as video-assisted thoracoscopic surgeries (VATS) and laser surgeries are the factors driving the growth of this segment.

On the basis of procedure, the lung cancer surgery market is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the global lung cancer surgery. These surgeries are widely adopted to confirm the diagnosis of lung cancer, remove tumours and scar tissue, or fix air leaks. Moreover, availability of skilled professional for performing thoracotomy and less time for surgery are the major factors that will drive the growth of this segment.

Geographically, North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.

The major factors contributing to the growth of the global lung cancer surgery market include the increasing incidence and prevalence of cancer, increasing lung cancer awareness campaigns, and rising aging population. On the other hand, high cost of lung cancer surgery is restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the lung cancer surgery market.

The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).

Research Coverage

Apart from comprehensive geographic and devices analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the lung cancer surgery market. The report analyses the lung cancer surgery market by device, procedure, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the lung cancer surgery market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the lung cancer surgery market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for lung cancer surgery across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the lung cancer surgery market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 SECONDARY DATA
  2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
  2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
  2.3.1 BOTTOM-UP APPROACH
  2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

3.1 INTRODUCTION
3.2 CONCLUSION

4 PREMIUM INSIGHTS

4.1 LUNG CANCER SURGICAL DEVICES MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE
4.3 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016-2021
4.4 LUNG CANCER SURGICAL DEVICES MARKET, BY REGION, 2016-2021

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Technological advancements in lung cancer treatment
    5.2.1.2 Increasing incidence and prevalence of lung cancer
    5.2.1.3 Rising geriatric population
    5.2.1.4 Increasing number of awareness initiatives aimed at early detection of cancer
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of lung cancer surgeries
  5.2.3 OPPORTUNITIES
    5.2.3.1 Untapped emerging markets
  5.2.4 CHALLENGES
    5.2.4.1 Entry barriers for new players
    5.2.4.2 Dearth of oncologists

6 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 SURGICAL INSTRUMENTS
  6.2.1 HAND INSTRUMENTS
    6.2.1.1 Staplers
    6.2.1.2 Forceps
    6.2.1.3 Retractors
    6.2.1.4 Rib shears
    6.2.1.5 Trocars
    6.2.1.6 Cutters
    6.2.1.7 Clamps
    6.2.1.8 Scissors
    6.2.1.9 Elevators
    6.2.1.10 Other hand instruments
6.3 MONITORING AND VISUALIZING SYSTEMS
  6.3.1 CAMERAS & VIDEO SUPPORT
  6.3.2 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
  6.3.3 ENDOSURGICAL EQUIPMENT

7 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE

7.1 INTRODUCTION
7.2 THORACOTOMY
  7.2.1 LOBECTOMY
  7.2.2 SLEEVE RESECTION
  7.2.3 SEGMENTECTOMY
  7.2.4 PNEUMONECTOMY
7.3 MINIMALLY INVASIVE SURGERIES

8 LUNG CANCER SURGERY MARKET, BY REGION

8.1 INTRODUCTION
8.2 NORTH AMERICA
  8.2.1 U.S.
  8.2.2 CANADA
8.3 EUROPE
8.4 ASIA
  8.4.1 CHINA
  8.4.2 JAPAN
  8.4.3 INDIA
  8.4.4 ROA
8.5 REST OF THE WORLD (ROW)

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 STRATEGIC OVERVIEW
9.3 MARKET SHARE ANALYSIS
9.4 COMPETITIVE SITUATION AND TRENDS
  9.4.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  9.4.2 PRODUCT LAUNCHES
  9.4.3 EXPANSIONS
  9.4.4 ACQUISITIONS
  9.4.5 OTHER DEVELOPMENTS

10 COMPANY PROFILES

(Overview, Products and Services, Financials, Strategy & Development)*

10.1 INTRODUCTION
10.2 ACCURAY INCORPORATED
10.3 ANGIODYNAMICS INC.
10.4 ETHICON US, LLC (JOHNSON & JOHNSON)
10.5 INTUITIVE SURGICAL INC.
10.6 OLYMPUS CORPORATION
10.7 TELEFLEX INCORPORATED
10.8 ACKERMANN INSTRUMENTE GMBH
10.9 KARL STORZ GMBH
10.10 SCANLAN INTERNATIONAL, INC.
10.11 TROKAMED GMBH

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

11 APPENDIX

11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 AVAILABLE CUSTOMIZATIONS
11.6 RELATED REPORTS
11.7 AUTHOR DETAILS

LIST OF TABLES

Table 1 LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 2 SURGICAL INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 3 SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 HAND INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 5 HAND INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 6 HAND INSTRUMENTS MARKET SIZE FOR STAPLERS, BY REGION, 2014–2021 (USD MILLION)
Table 7 HAND INSTRUMENTS MARKET SIZE FOR FORCEPS, BY REGION, 2014–2021 (USD MILLION)
Table 8 HAND INSTRUMENTS MARKET SIZE FOR RETRACTORS, BY REGION, 2014–2021 (USD MILLION)
Table 9 HAND INSTRUMENTS MARKET SIZE FOR RIB SHEARS, BY REGION, 2014–2021 (USD MILLION)
Table 10 HAND INSTRUMENTS MARKET SIZE FOR TROCARS, BY REGION, 2014–2021 (USD MILLION)
Table 11 HAND INSTRUMENTS MARKET SIZE FOR CUTTERS, BY REGION, 2014–2021 (USD MILLION)
Table 12 HAND INSTRUMENTS MARKET SIZE FOR CLAMPS, BY REGION, 2014–2021 (USD MILLION)
Table 13 HAND INSTRUMENTS MARKET SIZE FOR SCISSORS, BY REGION, 2014–2021 (USD MILLION)
Table 14 HAND INSTRUMENTS MARKET SIZE FOR ELEVATORS, BY REGION, 2014–2021 (USD MILLION)
Table 15 OTHER HAND INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 17 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE FOR CAMERAS & VIDEO SUPPORT, BY REGION, 2014–2021 (USD MILLION)
Table 19 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE FOR ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2014–2021 (USD MILLION)
Table 20 ENDOSURGICAL EQUIPMENT MARKET SIZE BY REGION, 2014–2021 (USD MILLION)
Table 21 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 22 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 23 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 24 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY, BY REGION, 2014–2021 (USD MILLION)
Table 25 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 26 OPEN LOBECTOMY VS. VATS: ANALYSIS OF COSTS, SURGERY TIME, AND LENGTH OF STAY
Table 27 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR LOBECTOMY, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 28 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR SLEEVE RESECTION, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 29 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR SEGMENTECTOMY, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 30 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR PNEUMONECTOMY, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 31 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2014–2021 (USD MILLION)
Table 32 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 33 LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2014–2021 (NO. OF PROCEDURES)
Table 36 LIST OF RELATED CONFERENCES IN NORTH AMERICA
Table 37 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 38 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 39 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 40 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 41 NORTH AMERICA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 42 U.S.: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 43 U.S.: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 44 U.S.: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 45 U.S.: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 46 CANADA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 47 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 48 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 49 CANADA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 50 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 51 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 52 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 53 EUROPE: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 54 ASIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 55 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2014–2021 (NO. OF PROCEDURES)
Table 56 ASIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 57 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 58 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 59 ASIA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 60 CHINA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 61 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 62 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 63 CHINA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 64 JAPAN: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 66 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 67 JAPAN: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 68 INDIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 69 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 70 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 71 INDIA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 72 ROA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 73 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 75 ROA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 76 ROW: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 79 ROW: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES)
Table 80 GROWTH STRATEGY MATRIX, 2014–2016
Table 81 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014–2016
Table 82 PRODUCT LAUNCHES, 2014–2016
Table 83 EXPANSIONS, 2014–2016
Table 84 ACQUISITIONS, 2014–2016
Table 85 OTHER DEVELOPMENTS, 2014–2016

LIST OF FIGURES

Figure 1 RESEARCH DESIGN
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 LUNG CANCER SURGERY MARKET: BOTTOM-UP APPROACH
Figure 4 LUNG CANCER SURGERY MARKET: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 7 GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2016 VS. 2021 (NO. OF PROCEDURES)
Figure 8 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
Figure 9 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY REGION
Figure 10 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 11 SURGICAL INSTRUMENTS SEGMENT TO DOMINATE THE GLOBAL LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 12 THORACOTOMY SEGMENT TO DOMINATE THE GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET IN 2016
Figure 13 ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 14 LUNG CANCER SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 15 LUNG CANCER SURGICAL DEVICES MARKET SEGMENTATION, BY TYPE
Figure 16 SURGICAL INSTRUMENTS WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL DEVICES MARKET DURING THE FORECAST PERIOD
Figure 17 THE THORACOTOMY SEGMENT WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL PROCEDURES MARKET DURING THE FORECAST PERIOD
Figure 18 THE LOBECTOMY SEGMENT WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY DURING THE FORECAST PERIOD
Figure 19 LUNG CANCER SURGICAL DEVICES MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2016–2021
Figure 20 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION (NO. OF PROCEDURES AND GROWTH RATE), 2016 VS 2021
Figure 21 NORTH AMERICA: LUNG CANCER SURGERY MARKET SNAPSHOT
Figure 22 U.S. TO DOMINATE THE NORTH AMERICAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 23 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE NORTH AMERICAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 24 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE U.S. LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 25 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE CANADIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 26 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE EUROPEAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 27 ASIA: LUNG CANCER SURGERY MARKET SNAPSHOT
Figure 28 CHINA ESTIMATED TO DOMINATE THE ASIAN MARKET IN 2016
Figure 29 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE ASIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 30 LOBECTOMY SURGERIES ACCOUNT FOR THE LARGEST SHARE IN THE ASIAN THORACOTOMY MARKET IN 2016
Figure 31 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE CHINESE LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 32 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE JAPANESE MARKET IN 2016
Figure 33 SURGICAL INSTRUMENTS TO DOMINATE THE INDIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 34 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE ROA MARKET IN 2016
Figure 35 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE ROW LUNG CANCER SURGICAL DEVICES MARKET IN 2016
Figure 36 KEY DEVELOPMENTS WITNESSED IN THE LUNG CANCER SURGERY MARKET, 2014–2016
Figure 37 LUNG CANCER SURGERY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 38 GEOGRAPHIC REVENUE MIX OF THE TOP SIX MARKET PLAYERS
Figure 39 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2015)
Figure 40 ANGIODYNAMICS INC.: COMPANY SNAPSHOT (2015)
Figure 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015)
Figure 42 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2015)
Figure 43 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2015)
Figure 44 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2015)
Skip to top


Ask Your Question

Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: